Anthrax antigen

Also known as: Bacillus anthracis antigen

Active ingredient description

Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J07AC01
Anthrax antigen
J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AC Anthrax vaccines
Discover more medicines within J07AC01

Medicines

Anthrax antigen is the active ingredient of these drugs:

Drug
Countries
BIOTHRAX

Poland Singapore United Kingdom United States

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
BIOTHRAX Suspension for injection
Structured Product Labeling (SPL/PLR)
US

Unique ingredient identifier (UNII)

OSR4FXO1IU - ANTHRAX PROTECTIVE ANTIGEN

SNOMED-CT

409499007 - Protective antigen of anthrax toxin (substance)

Next: Usage